U.S. Markets open in 5 hrs 19 mins
  • S&P Futures

    3,633.00
    +0.25 (+0.01%)
     
  • Dow Futures

    29,992.00
    -6.00 (-0.02%)
     
  • Nasdaq Futures

    12,105.50
    +29.50 (+0.24%)
     
  • Russell 2000 Futures

    1,851.80
    +0.30 (+0.02%)
     
  • Crude Oil

    45.39
    +0.48 (+1.07%)
     
  • Gold

    1,808.40
    +3.80 (+0.21%)
     
  • Silver

    23.41
    +0.11 (+0.47%)
     
  • EUR/USD

    1.1912
    +0.0016 (+0.1310%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.67
    -0.99 (-4.37%)
     
  • GBP/USD

    1.3356
    -0.0002 (-0.0160%)
     
  • USD/JPY

    104.3800
    -0.1000 (-0.0957%)
     
  • BTC-USD

    19,063.09
    +209.11 (+1.11%)
     
  • CMC Crypto 200

    377.84
    +8.09 (+2.19%)
     
  • FTSE 100

    6,440.59
    +8.42 (+0.13%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Horizon Therapeutics plc to Release Third-Quarter 2020 Financial Results and Host Webcast on Nov. 2, 2020

·1 min read

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its third-quarter 2020 financial results will be released on Monday, Nov. 2, 2020. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.

The live webcast and a replay may be accessed at http://ir.horizontherapeutics.com. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay of the webcast will be available approximately two hours after the live webcast.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005226/en/

Contacts

Investors:
Tina Ventura
Senior Vice President,
Investor Relations
investor-relations@horizontherapeutics.com

Ruth Venning
Executive Director,
Investor Relations
investor-relations@horizontherapeutics.com

U.S. Media:
Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com

Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie